Youngene Therapeutics Co. Ltd. is headquartered in the ZhangJiang Medicine Valley located in Shanghai, China. We are an innovative biopharmaceutical enterprise focused on the development of novel therapeutics for the treatment of metabolic and cardiovascular diseases including diabetes and heart failure. We have won numerous local industry awards for our outstanding research and development capabilities.
We are currently in process of planning additional clinical studies in the areas of T1D, Heart Failure, and Chronic Kidney Disease.